Dr. Stacey Trooskin

C a Difference / Hepatitis C, Jonathan Lax Treatment Center, Medical Leadership

Chief Medical Officer

215-790-1788, x225

MD, PhD, MPH

Medical School: Rutgers University, Robert Wood Johnson Medical School and Rutgers School of Public Health

Residency: Hospital of the University of Pennsylvania

Bio

Education & Training

Hospital of the University of Pennsylvania, Philadelphia, PA

Fellowship in Infectious Diseases, Division of Infectious Diseases, Department of Internal Medicine, 2010- 2012

Residency in Internal Medicine, Department of Internal Medicine, 2007- 2010

Rutgers University, Robert Wood Johnson Medical School and Rutgers School of Public Health

Doctor of Medicine (MD), May 2007

Doctor of Philosophy in Public Health (PhD), October 2005

Concentration in Epidemiology

Yale University, School of Epidemiology and Public Health

Master of Public Health (MPH), May 2001

Concentration in Epidemiology of Microbial Diseases

University of Pennsylvania

Bachelor of Arts, May 1998

Biology Major

Fellowship

Hospital of the University of Pennsylvania

Fellowship in Infectious Diseases, Division of Infectious Diseases,
Department of Internal Medicine

Spotlight On

Karam Mounzer, MD

Dr. Mounzer identified two major gaps in the care of patients with HIV/hepatitis C (HCV) co-infection, and the complexity of multidrug-resistant HIV treatment. He is involved with many clinical trials focusing on drug development and better understanding of HIV immunopathogenesis with the Wistar Institute. He is involved in teaching and mentoring.

Learn More

Dr. Mario Cruz

Dr. Mario Cruz Dr. Cruz is a board certified pediatrician who serves as the Medical Director for our Pediatrics and Adolescent Health Center. He has presented and/or published in the fields of community violence and domestic violence prevention, quality improvement, behavioral health, curriculum development and mentorship. In 2019 he received the Greater Philadelphia Social Innovation Award for Innovations in Healthcare.